Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion type Assertion NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_head.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion description "[Around 20% of breast cancers (BC) show ERBB2 gene amplification and overexpression of the ERBB2 tyrosine kinase receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_provenance.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion evidence source_evidence_literature NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_provenance.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion SIO_000772 20932292 NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_provenance.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion wasDerivedFrom befree-20140225 NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_provenance.
- NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_assertion wasGeneratedBy ECO_0000203 NP561673.RA-pzKa2p5OvvphcOVCPwDPzbCljJtP5jOGu84_EaCptU130_provenance.